Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NordiNet International Outcome Study (NordiNet IOS)
2008-001674-32Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Small for gestational age (SGA), Turner syndrome (TS) and growth hormone deficiency (GHD), sponsored by Novo Nordisk. Primary endpoints: Effectiveness endpoints and Safety endpoints. Started Aug 2008; status: completed.
02
Drugs
somatropin
03
Conditions
Small for gestational age (SGA)Turner syndrome (TS)growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2008-001674-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001674-32.